Cited by 74Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes Management and Education

Consensus Report of the Coalition for Clinical Research—Self-Monitoring of Blood Glucose

Open access
Klonoff, David C., Bergenstal, Richard, Blonde, Lawrence, Boren, Suzanne Austin, Church, Timothy S., Gaffaney, Jenifer, Jovanovič, Lois, Kendall, David M. +14 more·2008·Journal of Diabetes Science and Technology

Abstract

The Coalition for Clinical Research—Self-Monitoring of Blood Glucose Scientific Board, a group of nine academic clinicians and scientists from the United States and Europe, convened in San Francisco, California, on June 11–12, 2008, to discuss the appropriate uses of self-monitoring of blood glucose (SMBG) and the measures necessary to accurately assess the potential benefit of this practice in noninsulin-treated type 2 diabetes mellitus (T2DM). Thirteen consultants from the United States, Europe, and Canada from academia, practice, and government also participated and contributed based on their fields of expertise. These experts represent a range of disciplines that include adult endocrinology, pediatric endocrinology, health education, mathematics, statistics, psychology, nutrition, exercise physiology, and nursing. This coalition was organized by Diabetes Technology Management, Inc. Among the participants, there was consensus that: protocols assessing the performance of SMBG in noninsulin treated T2DM must provide the SMBG intervention subjects with blood glucose (BG) goals and instructions on how to respond to BG data in randomized controlled trials (RCTs); intervention subjects in clinical trials of SMBG-driven interventions must aggressively titrate their therapeutic responses or lifestyle changes in response to hyperglycemia; control subjects in clinical trials of SMBG must be isolated from SMBG-driven interventions and not be contaminated by physician experience with study subjects receiving a SMBG intervention; the best endpoints to measure in a clinical trial of SMBG in T2DM include delta Hemoglobin A1c levels, hyperglycemic events, hypoglycemic events, time to titrate noninsulin therapy to a maximum necessary dosage, and quality of life indices; either individual randomization or cluster randomization may be appropriate methods for separating control subjects from SMBG intervention subjects, provided that precautions are taken to avoid bias and that the sample size is adequate; treatment algorithms for assessing SMBG in T2DM may include a dietary, exercise, and/or medication intervention, which are all titratable according to the SMBG values; the medical literature contains very little information about the performance of SMBG in T2DM from RCTs in which treatment algorithms were used for dysglycemic values; and research on the performance of SMBG in T2DM based on sound scientific principles and clinical practices is needed at this time.

Integrity signals

Registry

Crossref · 10.1177/193229680800200612

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The study used a comprehensive approach to address design limitations of previous studies: a cluster-randomized design; an A1C inclusion criterion of ≥7.5%; a highly structured protocol; and per-protocol analyses.

    “We used a comprehensive approach to address the design limitations of previous studies (23): a cluster-randomized design; an A1C inclusion criterion of ≥7.5%; a highly structured protocol that led to actionable outcomes for both patients and physicians; and a set of PP analyses to determine the effects of protocol completion.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Klonoff, D. C., Bergenstal, R., Blonde, L., Boren, S. A., Church, T. S., Gaffaney, J., Jovanovič, L., Kendall, D. M., Kollman, C., Kovatchev, B. P., Leippert, C., Owens, D. R., Polonsky, W. H., Reach, G., Renard, E., Riddell, M. C., Rubin, R. R., Schnell, O., Siminiero, L. M., Vigersky, R. A., Wilson, D. M., & Wollitzer, A. O.
Affiliations
Mills Peninsula Health Services (US)
Corresponding author
Klonoff, David C.
Venue
Journal of Diabetes Science and Technology
Published
2008-11
Volume
2
Issue
6
Pages
1030-1053
ISSN
1932-2968 (ISSN-L)
OpenAlex
W2123142366
Cited by
74
References
8
Citations by year
2026: 1 · 2022: 1 · 2021: 2 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 6 · 2014: 4 · 2013: 6 · 2012: 10
FWCI
8.71
Type
journal article
Language
en
Open access
Locations
  • Journal of Diabetes Science and Technology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
self-monitoring of blood glucose, type 2 diabetes, clinical trial design, cluster randomization, treatment algorithm, glycemic control, HbA1c, hypoglycemia, hyperglycemia, lifestyle intervention, dose titration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review